Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with INNO-LiPA HPV genotyping extra assay

Journal of Clinical Microbiology

Volumn 49, Issue 5, 2011, Pages 1907-1912

  Else, Elizabeth A ^a   Swoyer, Ryan ^a   Zhang, Yuhua ^a   Taddeo, Frank J ^a,d   Bryan, Janine T ^a   Lawson, John ^b   Van Hyfte, Inez ^b   Roberts, Christine C ^a,c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Innogenetics   (United States)

^c UG 3CD 28 ^*  (United States)

^d PPD Vaccines and Biologics Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; WART VIRUS VACCINE;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; LIMIT OF DETECTION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION; VIRUS LIKE AGENT; WART VIRUS;

CAPSID PROTEINS; FEMALE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

EID: 79955541361     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00236-10     Document Type: Article

References (16)

1. Baleriola, C., D. Millar, J. Melki, N. Coulston, P. Altman, N. Rismanto, and W. Rawlinson. 2008. Comparison of a novel HPV test with the Hybrid Capture II (hcII) and a reference PCR method shows high specificity and positive predictive value for 13 high-risk human papillomavirus infections. J. Clin. Virol. 42:22-26.
2. Castle, P. E., C. Porras, W. G. Quint, A. C. Rodriguez, M. Schiffman, P. E. Gravitt, P. Gonzalez, H. A. Katki, S. Silva, E. Freer, L. J. Van Doorn, S. Jimenez, R. Herrero, and A. Hildesheim. 2008. Comparison of two PCRbased human papillomavirus genotyping methods. J. Clin. Microbiol. 46: 3437-3445.
3. Cricca, M., F. Bonvicini, S. Venturoli, S. Ambretti, G. Gallinella, G. Gentilomi, M. Musiani, and M. Zerbini. 2004. Efficient treatment of paraffinembedded cervical tissue for HPV DNA testing by HC-II and PCR assays. J. Clin. Virol. 29:137-140.
4. Husnjak, K., M. Grce, L. Magdic, and K. Pavelic. 2000. Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens. J. Virol. Methods 88:125-134.
5. Iftner, T., L. Germ, R. Swoyer, S. K. Kjaer, J. G. Breugelmans, C. Munk, F. Stubenrauch, J. Antonello, J. T. Bryan, and F. J. Taddeo. 2009. Study comparing human papillomavirus (HPV) real-time multiplex PCR and Hybrid Capture II INNO-LiPA v2 HPV genotyping PCR assays. J. Clin. Microbiol. 47:2106-2113.
6. Klug, S. J., A. Molijn, B. Schopp, B. Holz, A. Iftner, W. Quint, P. J. F. Snijders, K. U. Petry, S. K. Kjaer, C. Munk, and T. Iftner. 2008. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. J. Med. Virol. 80:1264-1274.
7. Munoz, N., F. X. Bosch, S. deSanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, and C. J. Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
8. Munoz, N., R. Manalastas, Jr., P. Pitisuttithum, D. Tresukosol, J. Monsonego, K. Ault, C. Clavel, J. Luna, E. Myers, S. Hood, O. Bautista, J. Bryan, F. J. Taddeo, M. T. Esser, S. Vuocolo, R. M. Haupt, E. Barr, and A. Saah. 2009. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. Lancet 373:1949-1957.
9. Roberts, C. C., A. S. Tadesse, J. Sands, T. Halvorsen, T. L. Schofield, A. Dalen, F. E. Skjeldestad, and K. U. Jansen. 2006. Detection of HPV in Norwegian cervical biopsy specimens with type-specific PCR and reverse line blot assays. J. Clin. Virol. 36:277-282.
10. Safaeian, M., R. Herrero, A. Hildesheim, W. Quint, E. Freer, L. J. Van Doorn, C. Porras, S. Silva, P. Gonzalez, M. C. Bratti, A. C. Rodriguez, and P. Castle. 2007. Comparison of the SPF10-LiPA system to the Hybrid Capture 2 assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica. J. Clin. Microbiol. 45:1447-1454.
11. Soderlund-Strand, A., P. Rymark, P. Andersson, J. Dillner, and L. Dillner. 2005. Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia. J. Clin. Microbiol. 43:3260-3266.
12. van Doorn, L. J., W. Quint, B. Kleter, A. Molijn, B. Colau, M. T. Martin, I. Kravang, N. Torrez-Martinez, C. L. Peyton, and C. M. Wheeler. 2002. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF10 line probe assay. J. Clin. Microbiol. 40:979-983.
13. Villa, L. L. 2007. Overview of the clinical development and results of a quadrivalent HPV (types 6, 11, 16, 18) vaccine. Int. J. Infect. Dis. 11:S17-S25.
14. Villa, L. L., R. L. Costa, C. A. Petta, R. P. Andrade, K. A. Ault, A. R. Guiliano, C. M. Wheeler, L. A. Koutsky, C. Malm, M. Lehtinen, F. E. Skjeldestad, S. E. Olsson, M. Steinwall, D. R. Brown, R. Kurman, B. M. Ronnett, M. H. Stoler, A. Ferenczy, D. M. Harper, G. M. Tamms, J. Yu, L. Lupinacci, R. Railkar, F. J. Taddeo, K. U. Jansen, M. T. Esser, H. L. Sings, A. J. Saah, and E. Barr. 2005. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicenter phase II efficacy trial. Lancet Oncol. 6:271-278.
15. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19. (Pubitemid 29406813)
16. WHO. 2006. Initiative for vaccine research. Human papillomavirus. WHO, Geneva, Switzerland. http://www.who.int/vaccine-research/diseases/viral-cancers/ en/index3.html.